BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 2464963)

  • 21. [Chemotherapy of malignant melanoma].
    Ishihara K; Yamazaki N; Asano K
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1287-92. PubMed ID: 7688498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chemotherapy of malignant melanoma].
    Jedrzejczak WW
    Pol Arch Med Wewn; 1998 Oct; 100(4):294-9. PubMed ID: 10335037
    [No Abstract]   [Full Text] [Related]  

  • 23. Chemotherapy of disseminated melanoma with bleomycin, vincristine, CCNU, and DTIC (BOLD regimen). The Prudente Foundation Melanoma Study Group.
    Cancer; 1989 May; 63(9):1676-80. PubMed ID: 2467736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Combination chemotherapy of disseminated skin melanoma with nitrosomethylurea].
    Perevodchikova NJ; Moros LW; Kogonia LM
    Arch Geschwulstforsch; 1986; 56(4):273-81. PubMed ID: 3530176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant therapy of cutaneous melanoma -- current status.
    Hansson J
    Acta Oncol; 2006; 45(4):369-72. PubMed ID: 16760171
    [No Abstract]   [Full Text] [Related]  

  • 26. [Control of multiple skin and lung metastasis of malignant melanoma by combined DAV and OK-432 chemoimmunotherapy in association with large-scale administration of indomethacin].
    Maeda K; Miura S; Kawamura M; Jimbow K
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2434-7. PubMed ID: 6497401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. More support for the judicious use of high-dose interleukin-2 in patients with advanced melanoma.
    McDermott DF; Atkins MB
    J Clin Oncol; 2007 Sep; 25(25):3791-3. PubMed ID: 17761967
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute myocardial infarction induced by cisplatin-based combination chemotherapy for malignant melanoma: a case report.
    Fukunaga T; Soejima H; Sugamura K; Kojima S; Sugiyama S; Sakamoto T; Yoshimura M; Tanoue T; Kageshita T; Ono T; Ogawa H
    J Cardiol; 2006 Apr; 47(4):191-5. PubMed ID: 16637253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [At the front line of malignant melanoma, great maneuvers: to cut the road to Bcl2 and "attack with chemotherapy"].
    Bénard J
    Bull Cancer; 1998 Jun; 85(6):520-1. PubMed ID: 9752277
    [No Abstract]   [Full Text] [Related]  

  • 30. Chemotherapy, cytokines, and biochemotherapy for melanoma.
    Eton O
    Cancer Chemother Biol Response Modif; 2005; 22():739-48. PubMed ID: 16110637
    [No Abstract]   [Full Text] [Related]  

  • 31. Combination chemotherapy with dacarbazine and lomustine in disseminated malignant melanoma.
    Joensuu H; Asola R; Minn H
    Acta Radiol Oncol; 1986; 25(3):177-9. PubMed ID: 3020881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complete remission of brain metastases in three patients with stage IV melanoma treated with BOLD and G-CSF.
    Bottoni U; Bonaccorsi P; Devirgiliis V; Panasiti V; Borroni RG; Trasimeni G; Clerico R; Calvieri S
    Jpn J Clin Oncol; 2005 Sep; 35(9):507-13. PubMed ID: 16120623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of S100 protein and MIA protein as serum marker for malignant melanoma.
    Djukanovic D; Hofmann U; Sucker A; Rittgen W; Schadendorf D
    Anticancer Res; 2000; 20(3B):2203-7. PubMed ID: 10928178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Durable complete responses in metastatic melanoma treated with interleukin-2 in combination with interferon alpha and chemotherapy.
    Legha SS
    Semin Oncol; 1997 Feb; 24(1 Suppl 4):S39-43. PubMed ID: 9122733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic chemotherapy in the treatment of malignant melanoma.
    Lens MB; Eisen TG
    Expert Opin Pharmacother; 2003 Dec; 4(12):2205-11. PubMed ID: 14640919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The course of melanoma-associated vitiligo: report of a case.
    Daneshpazhooh M; Shokoohi A; Dadban A; Raafat J
    Melanoma Res; 2006 Aug; 16(4):371-3. PubMed ID: 16845334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [In vitro drug sensitivity profiling in melanoma].
    Ugurel S
    J Dtsch Dermatol Ges; 2008 Jul; 6(7):611. PubMed ID: 18611186
    [No Abstract]   [Full Text] [Related]  

  • 38. New therapies for malignant melanoma.
    Hancock B
    Practitioner; 1989 Oct; 233(1477):1385-6, 1388. PubMed ID: 2482487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of advanced melanoma with a combination of interferon and chemotherapy].
    Pyrhönen S; Hahka-Kemppinen M; Muhonen T
    Duodecim; 1993; 109(10):885-92. PubMed ID: 7520386
    [No Abstract]   [Full Text] [Related]  

  • 40. Lomustine, vincristine, and procarbazine in the treatment of metastatic malignant melanoma.
    Shelley W; Quirt I; Bodurtha A; Iscoe N; Russell J; Paterson A; Young V
    Cancer Treat Rep; 1985 Sep; 69(9):941-4. PubMed ID: 2992784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.